Page last updated: 2024-08-25

1-ethyl-2-benzimidazolinone and n-methylaspartate

1-ethyl-2-benzimidazolinone has been researched along with n-methylaspartate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buño, W; Fernández de Sevilla, D; Galván, E; Garduño, J	1

Other Studies

1 other study(ies) available for 1-ethyl-2-benzimidazolinone and n-methylaspartate

Article	Year
1-Ethyl-2-benzimidazolinone (EBIO) suppresses epileptiform activity in in vitro hippocampus. Neuropharmacology, 2005, Volume: 49, Issue:3 Topics: Action Potentials; Algorithms; Animals; Anticonvulsants; Apamin; Benzimidazoles; Calcium Channel Agonists; Electric Stimulation; Electrophysiology; Epilepsy; Excitatory Amino Acid Agonists; Hippocampus; In Vitro Techniques; Membrane Potentials; N-Methylaspartate; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Pyramidal Cells; Rats; Small-Conductance Calcium-Activated Potassium Channels; Synaptic Transmission	2005

Article

Year

1-Ethyl-2-benzimidazolinone (EBIO) suppresses epileptiform activity in in vitro hippocampus.

Neuropharmacology, 2005, Volume: 49, Issue:3

Topics: Action Potentials; Algorithms; Animals; Anticonvulsants; Apamin; Benzimidazoles; Calcium Channel Agonists; Electric Stimulation; Electrophysiology; Epilepsy; Excitatory Amino Acid Agonists; Hippocampus; In Vitro Techniques; Membrane Potentials; N-Methylaspartate; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Pyramidal Cells; Rats; Small-Conductance Calcium-Activated Potassium Channels; Synaptic Transmission

2005